Browsing: Longevity Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for longevity risk analysis, commentary and insights.
Fitch Ratings has a ‘neutral’ outlook for North American life insurers for 2026 despite a more challenging backdrop.
Greg Winterton caught up with Dr. Joshua Funder, CEO and Managing Director of Household Capital, to discuss the current state of and outlook for the reverse mortgage sector of the Australian securitisation market in this month’s Q&A.
Bodycote UK’s Pension Scheme has completed a £60m bulk purchase annuity buy-in with PIC. The transaction secures the benefits of all 680 scheme members.
€1.3bn longevity swap reinsurance agreement covers a portion of the defined benefit pensions included in a pension buy‑out and marks Pacific Life Re’s second longevity reinsurance transaction in the Netherlands.
The buy-in, covering both pensioners and deferred members, secures the benefits of over 3,600 members, while removing funding and investment risk for the scheme.
£113m bulk purchase annuity full buy-in secures the benefits of all 355 Section members within the scheme.
The deal secures the pension benefits of over 3,000 members of the Avon Cosmetics Pension Plan.
The deal secures the pension benefits of over 3,000 members of the Senior plc Pension Plan.
£240m transaction, completed in December 2025, protects the pensions of all of the remaining 1,852 scheme members whose policies were yet to be insured, including 924 pensioners and their dependants as well as a further 928 deferred members.
New policies that will fuel future trades in the life settlement market continue to be issued in healthy volumes, but in real terms, are slowly contracting.